Assessment of Adverse Cardiac Events Using Local Anesthesia With

Status Not yet recruiting

Clinical Trial Summary

The use of vasopressor supplement materials to local anesthetics is commonly used in procedures in various fields of dentistry, ENT (ear, nose, and throat), Plastic Surgery, Hand surgery and gastroenterology. Epinephrine is used to constrict small blood vessels, thus reducing bleeding during a medical procedure, reducing the toxicity by reducing systemic absorption of local anesthetic, and prolonging the duration and intensity of neural blockage created by the local anesthetic.

There are descriptions in the literature of cases in which the use of lidocain and adrenaline caused adverse cardiac events such as arrhythmias, edema and increase in blood pressure during ENT and dentistry procedures. As far as we know there has never been a systematic examination of the incidence and severity of arrhythmias during procedures with local anesthesia.

The purpose of the study:

1. To examine the prevalence and types of arrhythmias in patients undergoing a medical procedure performed under local anesthesia

2. Examine whether adding adrenaline to the local anesthetics affects the incidence of arrhythmia Determining the prevalence and types of arrhythmia will help determine the need for monitoring and type of monitoring required during procedures under local anesthesia.

The patients:

500 patients undergoing surgery or a medical procedure in which a local anesthetic is used at Meir Hospital. Patients with a medical history of known cardiac arrhythmia will not be included.

Methods:

Patients will undergo the medical procedure prescribed for them, using local anesthesia with or without adrenaline, at the discretion of the surgeon, in accordance with the usual routine being applied nowadays. The amount and type of anesthesia used will be registered. In addition to the routine monitoring that is currently performed (blood pressure cuff and non-invasive blood oxygen saturation) a continuous ECG monitoring device will be connected prior to the beginning of the surgical procedure, until the patient is discharged from the recovery room. The ECG monitoring results will be analyzed to detect arrhythmia. Side effects being reported by patients (palpitations, dizziness, fainting, CPR {cardiopulmonary resuscitation} ) will be recorded. In cases that an arrhythmia is detected, the type of arrhythmia and the presence of clinical symptoms will be investigated.

Clinical Trial Description

n/a

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Arrythmia

Clinical Trial Details

NCT number	NCT02738567
Study type	Observational [Patient Registry]
Source	Meir Medical Center
Contact
Status	Not yet recruiting
Phase	N/A
Start date	April 2016
Completion date	March 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00376532` - Extracellular Matrix Marker of Arrhythmia Risk (EMMA)	N/A
Recruiting	`NCT04848844` - The PAtients pResenTing With COngenital HeaRt DIseAse Register (ARTORIA-R)
Completed	`NCT06039397` - The Effect of Semi Fowler 30' Right Lateral on Cardiac Output in Acute Heart Failure	N/A
Completed	`NCT04025762` - 24/7 Closed-loop in Older Subjects With Type 1 Diabetes	N/A
Not yet recruiting	`NCT03619018` - All Inclusive KODEX - EPD™ Study Patient Specific Optimized Therapy (PSOT) Study
Completed	`NCT03786640` - Abbott Brady 3T MRI PMCF
Recruiting	`NCT05932602` - AVEIR DR Coverage With Evidence Development (CED) Study
Recruiting	`NCT05935007` - Aveir DR Real-World Evidence Post-Approval Study
Recruiting	`NCT01988064` - Face to Face vs. Group Training Methods on Pulse Rate Taking in Patients With Cardiovascular Diseases.	N/A
Recruiting	`NCT06310707` - Arrhythmia Identification in Syncope Patients: ePatch® Versus 24h Holter	N/A
Terminated	`NCT03481413` - Patient Specific Optimized Therapy Post-Market Clinical Follow-up Study
Recruiting	`NCT05443321` - Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes	N/A
Recruiting	`NCT03801681` - ARrhythmias in MYocarditis
Completed	`NCT03628534` - SERF VT Ablation Early Feasibility Study (EFS)	N/A
Recruiting	`NCT05034432` - The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients	Phase 4
Recruiting	`NCT04856267` - Exploration of Arrhythmia Burden in Cardiac Amyloidosis Using Implantable Loop Recorders
Completed	`NCT02401659` - Importance of Patient´s Satisfaction With Telemedicine Based on Monitoring Systems	N/A
Recruiting	`NCT05790642` - Comparison of Different Non-invasive Methods to Assess Pulse Wave Analysis
Recruiting	`NCT04833712` - Stereotactic Radioablation for the Treatment of Refractory Atrial Fibrillation	N/A
Not yet recruiting	`NCT06371937` - iPSC Biobank of Biomarkers Diversity in Cardiovascular Disease

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Assessment of Adverse Cardiac Events Using Local Anesthesia With Adrenaline

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms